Measurement and valuation of health providers' time for the management of childhood pneumonia in rural Malawi: an empirical study
- PMID: 27464679
- PMCID: PMC4964305
- DOI: 10.1186/s12913-016-1573-5
Measurement and valuation of health providers' time for the management of childhood pneumonia in rural Malawi: an empirical study
Abstract
Background: Human resources are a major cost driver in childhood pneumonia case management. Introduction of 13-valent pneumococcal conjugate vaccine (PCV-13) in Malawi can lead to savings on staff time and salaries due to reductions in pneumonia cases requiring admission. Reliable estimates of human resource costs are vital for use in economic evaluations of PCV-13 introduction.
Methods: Twenty-eight severe and twenty-four very severe pneumonia inpatients under the age of five were tracked from admission to discharge by paediatric ward staff using self-administered timesheets at Mchinji District Hospital between June and August 2012. All activities performed and the time spent on each activity were recorded. A monetary value was assigned to the time by allocating a corresponding percentage of the health workers' salary. All costs are reported in 2012 US$.
Results: A total of 1,017 entries, grouped according to 22 different activity labels, were recorded during the observation period. On average, 99 min (standard deviation, SD = 46) were spent on each admission: 93 (SD = 38) for severe and 106 (SD = 55) for very severe cases. Approximately 40 % of activities involved monitoring and stabilization, including administering non-drug therapies such as oxygen. A further 35 % of the time was spent on injecting antibiotics. Nurses provided 60 % of the total time spent on pneumonia admissions, clinicians 25 % and support staff 15 %. Human resource costs were approximately US$ 2 per bed-day and, on average, US$ 29.5 per severe pneumonia admission and US$ 37.7 per very severe admission.
Conclusions: Self-reporting was successfully used in this context to generate reliable estimates of human resource time and costs of childhood pneumonia treatment. Assuming vaccine efficacy of 41 % and 90 % coverage, PCV-13 introduction in Malawi can save over US$ 2 million per year in staff costs alone.
Keywords: Children; Malawi; PCV-13; Pneumococcal conjugate vaccine; Pneumonia; Provider costs; Time use.
Figures
Similar articles
-
Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.Vaccine. 2011 Sep 2;29(38):6686-94. doi: 10.1016/j.vaccine.2011.06.091. Epub 2011 Jul 13. Vaccine. 2011. PMID: 21745516
-
Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.Pediatr Infect Dis J. 2016 Nov;35(11):e353-e361. doi: 10.1097/INF.0000000000001288. Pediatr Infect Dis J. 2016. PMID: 27753771
-
The cost of the district hospital: a case study in Malawi.Bull World Health Organ. 1993;71(3-4):329-39. Bull World Health Organ. 1993. PMID: 8324852 Free PMC article.
-
Economic aspects of pneumococcal pneumonia: a review of the literature.Pharmacoeconomics. 2004;22(11):719-40. doi: 10.2165/00019053-200422110-00003. Pharmacoeconomics. 2004. PMID: 15250750 Review.
-
Pneumococcal conjugate vaccines in the prevention of childhood pneumonia.Acta Microbiol Immunol Hung. 2010 Mar;57(1):1-13. doi: 10.1556/AMicr.57.2010.1.1. Acta Microbiol Immunol Hung. 2010. PMID: 20350875 Review.
Cited by
-
Conditional cash transfers to retain rural Kenyan women in the continuum of care during pregnancy, birth and the postnatal period: protocol for a cluster randomized controlled trial.Trials. 2019 Mar 1;20(1):152. doi: 10.1186/s13063-019-3224-8. Trials. 2019. PMID: 30823886 Free PMC article.
-
Health workforce needs in Malawi: analysis of the Thanzi La Onse integrated epidemiological model of care.Hum Resour Health. 2024 Sep 27;22(1):66. doi: 10.1186/s12960-024-00949-2. Hum Resour Health. 2024. PMID: 39334127 Free PMC article.
-
Time to Recovery from Severe Pneumonia and Its Predictors Among Children 2-59 Months of Age Admitted to Pediatric Ward of Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Ethiopia: Retrospective Cohort Study.Pediatric Health Med Ther. 2021 Jul 21;12:347-357. doi: 10.2147/PHMT.S321184. eCollection 2021. Pediatric Health Med Ther. 2021. PMID: 34321951 Free PMC article.
-
Pulse oximetry and oxygen services for the care of children with pneumonia attending frontline health facilities in Lagos, Nigeria (INSPIRING-Lagos): study protocol for a mixed-methods evaluation.BMJ Open. 2022 May 2;12(5):e058901. doi: 10.1136/bmjopen-2021-058901. BMJ Open. 2022. PMID: 35501079 Free PMC article.
-
Systematic review of economic evaluations for paediatric pulmonary diseases.Cost Eff Resour Alloc. 2023 Apr 30;21(1):27. doi: 10.1186/s12962-023-00423-1. Cost Eff Resour Alloc. 2023. PMID: 37121992 Free PMC article.
References
-
- GAVI Alliance. The GAVI Alliance policy reference book. Geneva: GAVI Alliance; 2010.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources